Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
MASH Rec CARD (13)
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

1478 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 80
Fewer Newborns in Australia Have Cerebral Palsy

Fewer Newborns in Australia Have Cerebral Palsy

There are multiple factors which may play a role in the development of cerebral palsy, a neurological movement disorder. This condition can be caused by injuries to the brain at…

Continue Reading Fewer Newborns in Australia Have Cerebral Palsy
Could LMOD3 Be a Diagnostic Marker for Kleine-Levin Syndrome?

Could LMOD3 Be a Diagnostic Marker for Kleine-Levin Syndrome?

The main symptom of Kleine-Levin syndrome – excessive sleepiness (hypersomnolence) – is also a key characteristic of many other sleep disorders, such as narcolepsy. Additionally, there are currently no observed…

Continue Reading Could LMOD3 Be a Diagnostic Marker for Kleine-Levin Syndrome?
Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease

Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease

  Every year almost half of the fourteen thousand patients who have received bone marrow or stem cell transplants will develop chronic graft-versus-host disease (cGVHD). Currently, there are no options…

Continue Reading Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease
Researchers Investigate Pentosan Polysulfate Sodium to Treat Maroteaux-Lamy Syndrome

Researchers Investigate Pentosan Polysulfate Sodium to Treat Maroteaux-Lamy Syndrome

  According to a recent article, researchers at the WORLDSymposium revealed they are looking into using pentosan polysulfate sodium to treat Maroteaux-Lamy syndrome. MPS VI (Maroteaux-Lamy Syndrome) Maroteaux-Lamy syndrome is…

Continue Reading Researchers Investigate Pentosan Polysulfate Sodium to Treat Maroteaux-Lamy Syndrome
Dupixent for Eosinophilic Esophagitis (EoE) Accepted for Priority Review

Dupixent for Eosinophilic Esophagitis (EoE) Accepted for Priority Review

According to a recent article from WFMZ+, the FDA has recently approved Regeneron's supplemental Biologics License Application (sBLA) for Dupixent, granting it priority review. Dupixent, also known by the generic…

Continue Reading Dupixent for Eosinophilic Esophagitis (EoE) Accepted for Priority Review
Vijoice is FDA Approved for PIK3CA-Related Overgrowth Spectrum

Vijoice is FDA Approved for PIK3CA-Related Overgrowth Spectrum

According to a recent press release, the FDA has recently granted approval to Vijoice - also known under the generic name alpelisib - for the treatment of PIK3CA-related overgrowth spectrum…

Continue Reading Vijoice is FDA Approved for PIK3CA-Related Overgrowth Spectrum
Adverse Events Could Predict Neuroendocrine Tumor Therapy Effectiveness

Adverse Events Could Predict Neuroendocrine Tumor Therapy Effectiveness

A study recently published in the journal ESMO Open has documented new biomarkers which may be able to predict efficacy outcomes of antiangiogenic therapies (such as surufatinib) in patients diagnosed with neuroendocrine…

Continue Reading Adverse Events Could Predict Neuroendocrine Tumor Therapy Effectiveness
Chlorfenapyr Nets Can Reduce Pediatric Malaria Infections

Chlorfenapyr Nets Can Reduce Pediatric Malaria Infections

In 2020, the CDC estimates that there were 241 million cases of malaria globally, of which 627,000 people died. Unfortunately, many of the mortalities were associated with children in sub-Saharan…

Continue Reading Chlorfenapyr Nets Can Reduce Pediatric Malaria Infections
  • Go to the previous page
  • 1
  • …
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 185
  • Go to the next page
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info